DDW’s Megan Thomas speaks to experts from the drug discovery industry about their predictions on the future of stem cells in drug discovery.   Melissa Little, CEO of the Novo Nordisk Foundation Centre for Stem Cell Medicine  “In the stem cell space, 2023 has seen significant increases in the delivery of pluripotent stem cell-derived cell […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!